Market outlook of smoking cessation products
Technavio’s market research analyst predicts the global smoking cessation products market to grow steadily at a CAGR of over 18% during the forecast period. The increase in the number of smokers is the primary growth driver for this market. Smoking is considered a trend in countries such as Russia, Indonesia, and Armenia. As a result, more than 50% of the male population are smokers in this region. It is also estimated that at least 30% of the women in Austria, Chile, and France, and a higher percentage in Greece, are smokers. However, more people are opting for smoking cessation products as there is an increase in the awareness of the life-threatening consequences of smoking, thereby leading to the growth of the market.
Public awareness programs about the hazards of smoking are also expected to boost the market growth during the forecast period. For instance, the WHO observes May 31st as World No Tobacco Day with the intention to create awareness about the health risks associated with smoking and introduce effective policies to reduce tobacco consumption. Similarly, Mary Lanning Healthcare introduced an eight-session program called the Tobacco Awareness Program (TAP), which addresses all forms of tobacco consumption.
Product segmentation and analysis of the smoking cessation products market
- Smoking cessation drugs
- Nicotine replacement therapies (NRTs)
- E-cigarettes
The e-cigarettes segment dominated the market during 2015, with a market share of over 66%. E-cigarettes are cost-effective and considered less harmful, resulting in their rising consumption in the market as compared to rolling paper and filters. Although, the market for e-cigarettes displayed slow growth initially, it has gained traction from 2010 onward and will continue to grow over the next five years.
Geographical segmentation and analysis of the smoking cessation products market
Americas accounted for almost 47% of the market share during 2015 and is expected to grow at a CAGR of around 16% during the forecast period. The decline in smoker’s population due to rising health consciousness and the increased preference for the use of e-cigarettes and nicotine replacement therapy products are the primary drivers for the market growth in this region.
Competitive landscape and key vendors
The global smoking cessation products market is vigorously competitive, with vendors contending on the basis of price, quality, innovation, service, reputation, distribution, and promotion. The entry of tobacco manufacturing companies into this market has further increased the competition, thereby resulting in pharmaceutical companies losing their market shares.
The leading vendors in the market are -
- GlaxoSmithKline
- Imperial Tobacco
- NJOY
- Pfizer
- Reynolds American
Other prominent vendors in the market include 22nd Century Group, Alkalon, Altria Group, Aradigm Corporation, Arena Pharmaceuticals, Ballantyne Brands, BAT, CB Distributors, Cytos Biotechnology, Electronic Cigarettes International Group (Victory Electronic Cigarettes), Evotec, Gamucci, Japan Tobacco, Johnson & Johnson, LOGIC Technology, NAL Pharmaceuticals, Nicotek, Novartis, Revolymer, RR Chemicals, Selecta Biosciences, Target, The Harvard Drug Group, Vapor, VMR Products, Walgreens, Wal-Mart, and White Cloud.
Key questions answered in the report include
- What will the market size and the growth rate be in 2020?
- What are the key factors driving the global smoking cessation products market?
- What are the key market trends impacting the growth of the global smoking cessation products market?
- What are the challenges to market growth?
- Who are the key vendors in the global smoking cessation products market?
- What are the market opportunities and threats faced by the vendors in the global smoking cessation products market?
- What are the trending factors influencing the market shares of the Americas, APAC, and EMEA?
- What are the key outcomes of the five forces analysis of the global smoking cessation products market?
Technavio also offers customization on reports based on specific client requirement.
Related reports:
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
- Market overview
- Top-vendor offerings
PART 03: Market research methodology
- Research methodology
- Economic indicators
PART 04: Introduction
PART 05: World cigarette statistics: Per capita consumption per year
PART 06: Epidemiology
PART 07: Health implications of smoking
- Risk of tobacco smoke on non-smokers
PART 08: Regulations on tobacco use
- Impact of smoking bans on businesses
- Economic benefits to individuals
PART 09: Pipeline analysis
- NAL2762
- X-22
- APD356
- GSK598809
- SEL-068
- ARD-1600
PART 10: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis
PART 11: Market segmentation by type
- Global smoking cessation drugs market
- Global NRTs market
- Global e-cigarette market
PART 12: Market segmentation by availability
- Prescription products
- OTC products
PART 13: Geographical segmentation
- Global smoking cessation products market by geography 2015-2020
- Smoking cessation products market in Americas
- Smoking cessation products market in EMEA
- Smoking cessation products market in APAC
PART 14: Market drivers
- Increase in number of smokers
- Increase in teenage smoking
- Significant number of public awareness programs
- High awareness of risks associated with tobacco use
PART 15: Impact of drivers
PART 16: Market challenges
- Side effects associated with drugs and therapies
- Relapse after treatment
- Weak R&D on drugs
PART 17: Impact of drivers and challenges
PART 18: Market trends
- Increase in use of e-cigarettes
- Increased innovation in smoking cessation products
- Ban on tobacco advertisements
- Increased pictorial warnings on cigarette packages
PART 19: Vendor landscape
- Competitive scenario
- GlaxoSmithKline
- Imperial Tobacco
- NJOY
- Pfizer
- Reynolds American
- Other prominent vendors
PART 20: Appendix
PART 21: Explore Technavio